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Summary 
Exposure of BALB/c mice to mosquitoes infected with irradiated Plasmodium  berghei confers 
protective immunity against subsequent sporozoite challenge. Immunized mice challenged with 
viable sporozoites develop parasitemia when treated orally with substrate inhibitors of nitric oxide 
synthase (NOS). This suggests that the production of nitric oxide (NO) prevents the development 
of exoerythrocytic stages of malaria in liver. Liver tissue from immunized mice expressed maximal 
levels of mKNA for inducible NOS (iNOS) between 12 and 24 h after challenge with sporozoites. 
Intraperitoneal injection of neutralizing monoclonal antibody against  interferon 3/(IFN-3') or 
in vivo depletion of CD8 + T  cells, but not CD4 + T  cells, at the time of challenge blocked 
expression of iNOS mlLNA and ablated protection in immunized mice. These results show that 
both CD8 § T  cells and IFN-~/are important components in the regulation of iNOS in liver 
which contributes to the protective response of mice immunized with irradiated malaria sporozoites. 
IFN-3,, likely provided by malaria-specific CD8 + T cells, induces liver cells, hepatocytes and/or 
Kupffer cells, to produce NO for the destruction of infected hepatocytes or the parasite within 
these cells. 
W 
ithin minutes after an infected Anopheles  mosquito 
bites the vertebrate host, malaria sporozoites migrate 
to the liver and invade hepatocytes.  There, the parasite ma- 
tures,  and after  several days the infected hepatocytes lyse, 
releasing thousands of merozoites. Once in circulation, the 
parasite infects erythrocytes causing parasitemia. Prior exposure 
to irradiated sporozoites confers protective immunity (1, 2). 
This immunity is directed against liver stage malaria,  and 
does not protect against the blood stage malaria. 
CD8 + T  cells and IFN-3' are required for protective im- 
munity to sporozoite challenge. In vivo depletion of CD8 § 
T cells or neutralization of IFN-3~ blocks induction of effector 
activity at the hepatic stage, resulting in parasitaemia (3-5). 
In vitro studies show that IFN-qr kills parasites by stimulating 
malaria-infected  hepatocytes to produce nitric oxide (NO), 
and the addition of monomethyl-r-arginine (NGMMLA),  a 
substrate inhibitor of nitric oxide synthase (NOS), to pri- 
mary cultures of mouse hepatocytes reversed the antiparasitic 
effects of IFN-'y (6, 7). Human hepatocytes also respond to 
IFN-3' for NO production (8). As to whether human hepa- 
tocytes exhibit antimalaria activity when stimulated to pro- 
duce NO,  remains to be examined. 
At present, the antimalaria effector mechanism triggered 
by sporozoites in immunized animals is  not  fully under- 
stood. Presumably malaria-specific CD8 + T cells act directly 
against infected hepatocytes by recognizing malaria antigen 
on the cell surface (i.e., induction of CTLs) or malaria-specific 
lymphocytes release cytokines, such as IFN-3,, upon parasite 
stimulation, which induces an antimalarial response (3-5, 
9-12).  The relationship between CD8 + T cells, IFN-% and 
NO-mediated protection in sporozoite-immunized mice was 
explored by examining the effects of mAbs to IFN-y and 
to CD8 + T cells on induction of inducible NOS (iNOS) in 
liver and protection against sporozoite challenge. Our results 
show that NO production is required for protection in ir- 
radiated sporozoite-immunized  mice, and induction of iNOS 
in  liver  depends on  the presence  of CD8 +  T  cells  and 
IFN-3'. 
Materials and Methods 
Immunization  and  Challenge Protocol.  Female, 4-6-wk-old, 
BALB/CBYJ (The Jackson Laboratory, Bar Harbor, ME) mice were 
immunized by mosquito bite with irradiation-attenuated ANKA 
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Anopheles stephensi mosquitoes.  Sedated mice were placed on a nylon 
mesh screened container containing infected mosquitoes. Each mouse 
was removed after a minimum of five observed mosquito feedings 
over 5 min. This was done on week 0 and week 2. The same proce- 
dure was repeated on day of challenge except the mosquitoes were 
not irradiated.  Parasitemia or patency of experimental  animals was 
determined on Giemsa-stained  thin blood films. Individual mice 
were screened by daily blood film beginning on day 4 through day 
15 after challenge or until a positive parasitemia  was observed (2). 
L-Arginine Analogues.  Mice were treated by gastric instillation 
with either t-arginine, aminoguanidine,  NC-nitro-L-arginine,  am- 
monium  acetate  (Sigma  Chemical  Co.,  St.  Louis,  MO),  or 
N~MMLA (Calbiochem-Novabiochem Corp., San Diego, CA) in 
sterile  water.  The  treatments  were initiated  24 h  before viable 
sporozoite challenge and administered  as indicated  for 72 h. 
mRNA Analysis.  The presence ofiNOS mRNA  in liver was 
analyzed by reverse transcription (RT) of total RNA using oligo 
dT followed by PCR amplification  of the cDNA.  Frozen livers 
were disrupted with a Stomacher Lab 80 blender (Seward, London, 
England) in 6 ml of guanidinium isothiocyanate solution. After 
addition of CsC1 to 0.33 g/ml,  the RNA was pelleted  through 
a cushion of 5.7 M CsC1 at 155,000 g  for 16 h (Beckman Instru- 
ments, Inc., Polo Alto, CA). The RNA pellet was resuspended  in 
water and precipitated  in the presence of 2 M sodium acetate, pH 
5.2, and ethanol. The precipitate  was resuspended  and extracted 
with phenol/chloroform/isoamyl  alcohol, followed by precipita- 
tion with ethanol, cDNA was prepared by incubation of 5 #g of 
RNA (in  10/~1) at 65~  for 3 rain followed by the addition of 
15/zl of reverse transcriptase  reaction mixture (Promega Corp., 
Madison, WI), and 400 U of reverse transcriptase  (GIBCO BRL, 
Gaithersburg, MD) and incubated at 41~  for 1 h. Sense and an- 
tisense primers at  final concentration of 0.8 mM were added  to 
2/~1  of the cDNA reaction in a reaction volume of 50/zl and 
amplified with Amplitaq (Perkin Elmer Cetus, Norwalk, CT). The 
sense and antisense oligonucleotides for iNOS, obtained from the 
nucleotide sequence of the pMAC-NOS, were as follows: 5'-ATG 
GCT q~3C CCC TGG AAG TTT CTC-Y; 5'-CAG CTT CCA 
GCC TGG CCA GAT G-3'. The predicted  PCR product was 486 
bp (13, 14). The primers for jB-actin were: 5'-CGT GGG CCG 
CCC TAG GCA CCA GGG-3'; 5'-CGG AGG AAG AGG ATG 
CGG CAG TGG-3'. The predicted/8-actin PCR product was 605 
bp. The cycle conditions were 1.5 min at 94~  1.5 min at 55~ 
and 2 rain at 72~  for 40 cycles (iNOS) or 25 cycles (actin).  The 
PCR products were analyzed by electrophoresis  on 1.5% agarose 
gels.  The identity of the specific PCR product was verified by 
Southern blot analysis and hybridization with oligonudeotide probes 
specific for iNOS or B-actin  genes.  The hybridization for iNOS 
was ACT GGG GCA GTG GAG AGA TT, and the hybridization 
probe for/~-actin was GTA GCC ATC CAG GCT GCT GTG CT. 
Verification that the amplified product originated from RNA rather 
than DNA was determined by preparing duplicate cDNA samples 
without reverse transcriptase,  followed  by PCR amplification. 
Neutralization oflFN-9/.  Mice were injected  intraperitoneally 
1 d before sporozoite challenge with mAb to IFN-3~ (H22) or iso- 
type IgG control Ab (Organon Teknika Corp., West Chester,  PA) 
in sterile PBS. H22 was generously provided by Robert D. Schreiber 
(Washington University,  St.  Louis,  MO) (15). Three mice were 
killed at various  times and livers removed for RNA analysis. The 
remaining mice were evaluated  for parasitemia. 
Table  1.  Effects of Substrate lnhibitors for NOS  on Sporozoite Immunity 
Immune status  Infected/total  Protected  Patency 
Experiment  No.  1 
Experiment  No.  2 
%  d 
Naive*  15/15#  0*  5-7s 
+  t-arginine  15/15  0  6-7 
+  Ammonium acetate  15/15  0  5-6 
+  NGMMLA  15/15  0  5-6 
Immunized  1/15  93  6 
+  t-arginine  2/10  81  6-7 
+  Ammonium acetate  1/10  90  5 
+  NCMMLA  15/15  0  5-6 
Naive  8/8  0  6-7 
Immunized:  1/8  88  5 
+  NC-nitro-L-arginine  2/8  75  5-6 
+  Aminoguanidine  8/8  0  4-6 
" Naive and immunized BALB/c mice were exposed to P. berghei-infected mosquitoes as described in Materials and Methods. In experiment No. 1, 
0.5 ml of a 50 mM solution of t-arginine, ammonium acetate, or NGMMLA was orally administered twice daily. In experiment No. 2, 0.5 ml of 
25 mM solution, NG-nitro-L-arginine or aminoguanidine was administered once daily. 
# Number of mice that had infected erthrocytes by day 15 was defined as infected (2). 
S Potency is the days or range of days in which all of the infected mice exhibited parasitemia. 
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from mice exposed to malaria sporozoites. 
cDNAs were  generated  by reverse  transcription 
of RNAs isolated  from the liver of immune 
(A) and normal  (B) mice  at the indicated  times 
after exposure to mosquitoes  infected  with P. 
berghei, cDNA were amplified  by PCIL  with 
primers specific for iNOS or/3-actin (Actin) 
genes as described  in Materials  and Methods. 
(34) Base pair markers. 
Depletion of CD8 § and CD4 + T  Cells.  3 d before challenge, 
immunized mice were depleted of either CD8 + or CD4 + T cells 
by three daily intraperitoneal doses of 1 mg of either mAb 2.43 
(mouse IgG2a, anti-CD8 +) or GK1.5 (rat IgG2a, anti-L3T4, anti- 
CD4 +) and two mice from each group also received 1 mg con- 
trol Ab (mAb NSV3; anti-P, vivax) or rat Ig obtained from pooled 
normal rat serum. These purified antibodies were a gracious gift 
from  Stephen L.  Hoffman  (Naval Medical Research Institute, 
Bethesda, MD). On day of challenge, a mouse from each group 
was killed and microfluorometric analysis  was done on the spleen 
cells. Spleen cell preparations were 97%  depleted of each T cell 
population. 
Results and  Discussion 
In  Vivo  Effects  of N~  ~-Arginine  Analogues  on 
Sporozoite  Immunity.  To  determine if NO  participates in 
the protective response  to malaria,  immunized mice were 
treated orally with L-arginine  analogues before sporozoite 
challenge. Synthesized by NOS, NO is derived from L-arginine 
(16).  Substrate inhibitors  for  NOS,  aminoguanidine, and 
N~-substituted L-arginine analogues,  such as NGMMLA and 
NG-nitro-L-arginine,  are  shown to  suppress  NO  synthesis 
and NO-mediated events  both in vitro  and in vivo (16). 
BALB/c mice were immunized twice with irradiated spo- 
rozoites by the natural vector, A. stephensi mosquitoes, and 
treated orally with NGMMLA, NC-nitro-t-arginine, amino- 
guanidine, or control compounds (i.e., L-arginine, ammonium 
acetate)  (Table  1).  Mice were then challenged with viable 
sporozoites to  determine the animals'  state of protection. 
Oral administration of NOS inhibitors or controls began on 
the day of challenge and the regimen was continued for 4 d. 
All nonimmunized mice that were challenged with sporo- 
zoites developed patent blood infection.  In contrast, >90% of 
immunized mice were protected from challenge. Oral ad- 
ministration  of L-arginine  or  ammonium  acetate  had  no 
effect on protective immunity. However, all immunized mice 
that  were  given  NGMMLA  displayed  parasitemia within 
5-7 d. A recent report showed a similar in vivo effect with 
NGMMLA (17). 
Since iNOS is believed  to be a principal mechanism for 
cytotoxicity  against intracellular parasites, the enzyme source 
of NO involved in this protective response was addressed. 
In vitro  studies earlier  demonstrated that  NCMMLA and 
aminoguanidine are both potent inhibitors of iNOS, whereas 
NG-nitro-L-arginine  blocks the constitutive NOS and is rel- 
atively ineffective as an inhibitor of the inducible isoform (18, 
19). Immunized mice were given either NG-nitro-L-arginine 
or aminoguanidine (Table 1). NC-nitro-t-arginine had min- 
imal effect on protective immunity. In contrast, all immunized 
mice treated orally with aminoguanidine became infected. 
Collectively, these data show that immunized mice that re- 
ceived  substrate inhibitors for iNOS  (i.e.,  aminoguanidine 
or NGMMLA) became susceptible  to sporozoite challenge, 
whereas immunized mice that received NG-nitro-t-arginine, 
a compound more selective for the constitutive enzyme, re- 
mained  protected.  Thus,  interference with  the  cytokine- 
inducible NO pathway ablates a critical component in pro- 
tective immunity against malaria. 
Expression  of iNOS  mRNA  in  Livers  from  Immunized 
Mice.  To determine whether iNOS is present in the liver 
of protected mice, RNA was isolated from the livers of ei- 
ther normal or immune mice at different times after sporozoite 
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on Sporozoite Immunity 
Immune status  Infected/total  Protected  Patency 
%  d 
Naive*  5/5*  0*  5-6s 
Immunized:  0/5  100  - 
+  Control  IgG Ab  0/5  100  - 
+  Anti-IFN-7  mAb  5/5  0  7 
* Immunized BALB/c mice were exposed to P. bergkei-infected  mosqui- 
toes and injected intraperitoneally (100/~1) with 200/~g/mouse of either 
isotype control  IgG Ab or mAb to IFN-3" (15). 
* Number of mice that  had infected erthrocytes by day 15 was defined 
as infected (2). 
S The  range  of  days in  which  all  of  the  infected  mice  exhibited 
parasitemia. 
Effects of mAb to IFN-'y on Protection and Expression of  iNOS 
mRNA  in Liver of Immunized Mice.  To assess the relation- 
ship between IFN-% protection against sporozoite challenge, 
and induction of liver iNOS, immunized mice were challenged 
and treated with mAb against IFN-3'. As expected, immunized 
mice which  received anti-IFN-3,  mAb  at the  time of chal- 
Figure  2.  RT-PCK analysis  of mouse liver mRNAs for iNOS and actin 
after exposure to malaria sporozoites and neutralizing mAb to IFN-% As 
detailed in the Materials and Methods, KNA was isolated from the liver 
of immune mice at the indicated times after exposure to mosquitoes in- 
fected with P. berghei  and injected intraperitoneally with control Ab (A) 
and IFN-3' (B). 
challenge and analyzed for the presence of iNOS mRNA  by 
RT-PCR.  iNOS  was not  detectable  in  the livers of either 
immune or normal mice (data not  shown),  whereas iNOS 
was induced  in the livers of immune mice within  12 h  after 
sporozoite challenge  (Fig.  1).  The induction  of iNOS  was 
transient since maximal levels of iNOS mRNA  were detected 
between 12 and 24 h after challenge, but were not detectable 
by 48  h  after challenge.  In normal  mice,  faintly detectable 
levels of iNOS  mRNA  were  evident  after sporozoite chal- 
lenge.  Thus,  iNOS mRNA  is produced in the liver of mice 
upon  sporozoite challenge  and  this  may contribute  to pro- 
tective immunity. 
This  observation,  together  with  earlier  reports  demon- 
strating that induction of NO by IFN-3~-stimulated hepato- 
cytes prevents the development of P.  berghei in mouse hepa- 
tocytes, suggests that iNOS might be produced in the liver 
of immune  mice when  challenged  with  sporozoites  (7,  8). 
The administration  of neutralizing  mAbs against IFN-'y to 
immune mice can reverse immunity to sporozoite challenge 
(3, 4).  However, the effector mechanism induced by IFN-7 
in  vivo has  not  clearly been  demonstrated. 
Figure  3.  RT-PCR analysis  of mouse liver mKNAs for iNOS and actin 
after exposure to malaria sporozoites and depletion of CD8 + and CD4 + 
cells. KNA was isolated from the liver of immune mice at 24 h after ex- 
posure to mosquitoes infected with P. berghei  and injected intraperitoneally 
with control antibody (Con-Ab) or mAbs to CD4 + (anti-CD4)  or CD8 + 
(anti-CD8) cells, as described in Materials and Methods. 
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on Immunity 
Immune status  Infected/total  Protected 
Naive"  5/5~  0  s 
Immunized: 
+  control Ig  0/5  100 
+  anti-CD4 §  0/5  100 
+  anti-CD8 +  5/5  0 
* Immunized BALB/c  mice were exposed  to P. berghei-infected  mosqui- 
toes and injected intraperitoneaUy  with indicated Abs 3 d before  challenge 
as described in Materials and Methods. 
Number of mice that had infected erthrocytes by day 15 was defined 
as infected (2). 
lenge displayed parasitemia (Table 2). In contrast, immunized 
mice that were challenged with viable sporozoites and treated 
with isotype control IgG were protected. When RNA was 
isolated from the liver of challenged mice, iNOS mRNA was 
easily detectable by 12-24 h  after challenge in the control 
IgG treated animals  (Fig.  2).  However, we were unable to 
detect iNOS in the liver of challenged, IFN-3' mAb treated 
mice. Such observations support the idea that viable sporozoites 
trigger  malaria-specific T  ceUs to release  IFN-y, which in 
turn,  stimulates the iNOS pathway in infected hepatocytes 
and neighboring  Kupffer cells. 
Effects of CD8 + T Cell Depletion on Protective Immunity and 
Expression ofiNOS.  Both CD8 + and CD4 + T  cells are a 
rich source of IFN-%  Infiltrates  containing  predominately 
CD8 § and to a lesser extent CD4 §  are found in the livers 
of mice immunized with irradiated  sporozoites and challenged 
with viable sporozoites,  whereas  substantially less cellular 
infiltrates were found in nonimmunized mice that were chal- 
lenged (12). In agreement with earlier reports (3, 5), in vivo 
depletion of CD8 + T  cells with mAbs after immunization 
and before challenge results in parasitemia  (Table 3). Anti- 
CD8 treatment completely reversed protection, whereas anti- 
CD4 mAb had no effect. It is interesting  to note that  by 
depleting CD8 + T  cells,  expression of iNOS mRNA was 
inhibited in livers taken from immunized mice 24 h after chal- 
lenge (Fig. 3). In contrast, iNOS mKNA was present in the 
livers  of immunized  mice  depleted  of CD4 +  T  cells  (or 
treated with an irrelevant  Ab) 24 h  after challenge.  These 
data support the hypothesis that both IFN-3' and CD8 + T 
cells,  not CD4 + T  cells,  are required for induction of NO 
and protection  against  liver  stage malaria.  As to whether 
CD8 +  T  cells  influence  hepatic  iNOS  in  other  rodent 
malaria models remains to be investigated, because depletion 
of  CD8 +  T  cells  did  not  reverse  sporozoite  protection 
against P. yoeli in some immunized B10 congenic mouse strains 
(2) or against P. berghei strain NK65 in immunized BALB/c 
mice (20).  Aside from using a different rodent  malaria  (P. 
berghei ANKA done), our immunization and challenge pro- 
tocol was distinctively different from those of other reports 
(2, 20). Here, we immunized and challenged via the bite of 
(irradiated and nonirradiated)  infected mosquitoes. Introducing 
the sporozoite "naturally"  through  the bite of a mosquito 
is clearly different from injecting large amounts of isolated 
sporozoites intravenously. Such differences (i.e., frequency of 
immunizations,  number of sporozoites, routes of exposure, 
strains of malaria and mice) may influence the host response 
and outcome of the disease process. 
Taylor-Robinson et al. (21) reported that induction of NO 
by Thl CD4 + cells controls blood stage malaria.  Whereas 
Weiss et al. (22) have recently shown that CD4 + T  cells are 
required at the time of immunization for protection against 
sporozoites, CD4 + T  cells are involved in the development 
of protective immunity against liver stage malaria,  and are 
not essential for protection after animals have been immunized. 
In contrast,  CD8 + T  cells  are  involved in the effector re- 
sponse or induction  of effector activity (2, 3,  5, 9,  10).  A 
recent report  (17) suggests that  a T  cell-independent  (i.e., 
NK cells)  source for IFN-3/mediates  protective immunity 
against liver stage malaria, however, protection was never as- 
sessed in immunized animals depleted of NK cells.  Investi- 
gators  found  elevated  NOS  activity  upon  infection  with 
malaria.  It is interesting to note that we also found that in- 
travenous  injection  of  a  large  excess  (>106)  of  viable 
sporozoites into naive mice induces iNOS activity in liver, 
yet these mice develop parasitemia and ultimately die (data 
not shown). In response to high concentrations of sporozoites, 
the NO produced under these conditions is likely the result 
of NK cells producing IFN-3' during acute hepatic inflam- 
mation.  In a similar fashion, NOS expression in liver tissue 
can be induced by injecting bacterial products causing he- 
patic inflammation (23).  However, this vigorous immune re- 
sponse was insuf~cient to render protection.  Therefore, in- 
duction of NO activity is necessary,  but not suf~cient for 
protection  against  sporozoites. 
Here, we report that CD8 + T  cells directly regulate NO 
production in infected livers of immunized mice. Therefore, 
CD8 § T  cells in immunized mice may participate as cyto- 
toxic T cells, and facilitate the protective response by providing 
a source of IFN-% This study provides evidence that IFN-'y 
induction of the t-arginine-dependent  NO pathway in vivo 
is a necessary component for effector activity in sporozoite- 
immunized  animals,  and the first  to report  that  CD8 + T 
cells are required in the regulation of liver cells to produce 
NO for the elimination of infected hepatocytes or the malaria 
schizonts within  these cells. 
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